PULMONARY ARTERIAL HYPERTENSION
Adverse reaction reported in 22,095 FDA reports across 9 drugs.
22,095
Total Reports
9
Drugs Involved
Treprostinil
Most Reported Drug
Drugs Associated with PULMONARY ARTERIAL HYPERTENSION
Drugs where "PULMONARY ARTERIAL HYPERTENSION" was reported as an adverse event.
| # | Drug | Reports | % of Total |
|---|---|---|---|
| 1 | Treprostinil | 4,439 | |
| 2 | Ambrisentan | 3,337 | |
| 3 | Macitentan | 3,274 | |
| 4 | Tadalafil | 2,862 | |
| 5 | Bosentan | 2,290 | |
| 6 | Sildenafil | 1,990 | |
| 7 | Selexipag | 1,682 | |
| 8 | Riociguat | 1,115 | |
| 9 | Epoprostenol | 1,106 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. The presence of a drug in this list does not mean the drug caused pulmonary arterial hypertension. Always consult your healthcare provider.